576 related articles for article (PubMed ID: 29024949)
1. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.
Huddy JR; Huddy FMS; Markar SR; Tucker O
Dis Esophagus; 2018 Jan; 31(1):1-11. PubMed ID: 29024949
[TBL] [Abstract][Full Text] [Related]
2. Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: a systematic review.
Ahmed O; Bolger JC; O'Neill B; Robb WB
Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 31828290
[TBL] [Abstract][Full Text] [Related]
3. Preoperative enteral access is not necessary prior to multimodality treatment of esophageal cancer.
Jenkins TK; Lopez AN; Sarosi GA; Ben-David K; Thomas RM
Surgery; 2018 Apr; 163(4):770-776. PubMed ID: 29198770
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
Pellen MG; Sabri S; Razack A; Gilani SQ; Jain PK
Dis Esophagus; 2012 Jan; 25(1):48-53. PubMed ID: 21595778
[TBL] [Abstract][Full Text] [Related]
5. Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Jain R; Shaikh T; Yee JL; Au C; Denlinger CS; Handorf E; Meyer JE; Dotan E
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080840
[TBL] [Abstract][Full Text] [Related]
6. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
Bower M; Jones W; Vessels B; Scoggins C; Martin R
Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
[TBL] [Abstract][Full Text] [Related]
7. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.
Smith ZL; Gonzaga JE; Haasler GB; Gore EM; Dua KS
Dig Dis Sci; 2017 Jun; 62(6):1647-1656. PubMed ID: 28391413
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy.
Kanekiyo S; Takeda S; Iida M; Nishiyama M; Kitahara M; Shindo Y; Tokumitsu Y; Tomochika S; Tsunedomi R; Suzuki N; Abe T; Yoshino S; Hazama S; Ueno T; Nagano H
Nutrition; 2019 Mar; 59():96-102. PubMed ID: 30468936
[TBL] [Abstract][Full Text] [Related]
9. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy.
Huerter ME; Charles EJ; Downs EA; Hu Y; Lau CL; Isbell JM; McMurry TL; Kozower BD
Ann Thorac Surg; 2016 Sep; 102(3):948-954. PubMed ID: 27209608
[TBL] [Abstract][Full Text] [Related]
10. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer.
Dalton BGA; Friedant AJ; Su S; Schatz TAP; Ruth KJ; Scott WJ
J Laparoendosc Adv Surg Tech A; 2017 Dec; 27(12):1279-1283. PubMed ID: 28777676
[TBL] [Abstract][Full Text] [Related]
11. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
Siddiqui AA; Glynn C; Loren D; Kowalski T
Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
[TBL] [Abstract][Full Text] [Related]
12. Pre-therapy laparoscopic feeding jejunostomy is safe and effective in patients undergoing minimally invasive esophagectomy for cancer.
Ben-David K; Kim T; Caban AM; Rossidis G; Rodriguez SS; Hochwald SN
J Gastrointest Surg; 2013 Aug; 17(8):1352-8. PubMed ID: 23709367
[TBL] [Abstract][Full Text] [Related]
13. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?
Mungo B; Molena D; Stem M; Yang SC; Battafarano RJ; Brock MV; Lidor AO
Dis Esophagus; 2015 Oct; 28(7):644-51. PubMed ID: 25059343
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
15. Benefits versus risks: a prospective audit. Feeding jejunostomy during esophagectomy.
Gupta V
World J Surg; 2009 Jul; 33(7):1432-8. PubMed ID: 19387726
[TBL] [Abstract][Full Text] [Related]
16. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
17. Routes for early enteral nutrition after esophagectomy. A systematic review.
Weijs TJ; Berkelmans GH; Nieuwenhuijzen GA; Ruurda JP; van Hillegersberg R; Soeters PB; Luyer MD
Clin Nutr; 2015 Feb; 34(1):1-6. PubMed ID: 25131601
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of nutritional jejunostomy in the curative treatment of esophageal cancer.
Klevebro F; Johar A; Lagergren J; Lagergren P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30496419
[TBL] [Abstract][Full Text] [Related]
19. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.
Lin G; Han SY; Xu YP; Mao WM
Dis Esophagus; 2016 Nov; 29(8):1107-1114. PubMed ID: 26542065
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
